• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MDT PUERTO RICO OPERATIONS CO SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MDT PUERTO RICO OPERATIONS CO SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-40
Device Problems Migration or Expulsion of Device (1395); Material Deformation (2976); Unintended Movement (3026)
Patient Problems Pain (1994); Discomfort (2330)
Event Date 01/01/2015
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from the healthcare provider (hcp) regarding a patient who had been receiving bupivacaine, hydromorphone, and fentanyl via an implantable pump for non-malignant pain and post lumbar laminectomy syndrome. The hcp indicated they had not seen the patient since (b)(6) 2017. The patient¿s pump was last filled with medication on (b)(6) 2015. The drug was not replaced with saline. The patient was scheduled to see the doctor on (b)(6) 2018 to discuss and schedule a pump explant. It was indicated the device would be returned to the manufacturer for analysis. The following information was provided by the healthcare provider via the pump logs and chart notes. The patient was seen on (b)(6) 2015 for a pump refill. The patient stated that her pump had been moving more than it had in the past. The patient had a history of the pump being significantly tilted but was more so even now (relative to the day of the report, (b)(6) 2015). The pump was noted as being extremely tilted and a quarter rotated with minimal tenderness. The physician was able to rotate the pump in order to obtain access to the refill port with minimal difficulty. The patient was otherwise currently in good health. The pump was refilled with 7. 5 mg/ml of bupivacaine, 1. 5 mg/ml of hydromorphone, and 375 mcg/ml of fentanyl. The device was interrogated and the correct concentration and volume were confirmed along with the expected residual volume of 8. 3 milliliters (mls). No complications were noted. The device was interrogated and found to be in ¿pump in safe state¿ which occurred the day before, (b)(6) 2015 at 11:46 a. M. (please see mfr report # 3004209178-2015-18636). The elective replacement indicator (eri) was currently at 30 months. The pump was refilled and programmed to deliver an increased concentration of fentanyl and decreased concentration of hydromorphone and bupivacaine. On (b)(6) 2015 the patient was seen for a routine consideration for resumption of intrathecal infusion therapy. The hcp discussed the possibility of replacing the patient¿s pump and also possibly replacing the catheter (please see mfr report # 3004209178-2018-15637). The patient¿s past medical history included coronary artery disease, peripheral neuropathy, cardiac arrhythmia, anemia, hyperlipidemia, neuropathy, hypertension, esophageal reflux, constipation, osteoarthritis, allergic rhinitis, and myocardial infraction. The patient had a stent placed in their left anterior descending artery (b)(6) 2011, a lumbar spinal fusion 2002, and a cholecystectomy. Allergies included codeine and baclofen. On (b)(6) 2016 the patient had an exam for a follow-up on her medication and pre-evaluation prior to having her intrathecal pump exchanged and catheter revised. The patient was not prepared for their upcoming pump replacement, which was scheduled for (b)(6) 2016. The patient requested to have the procedure moved out a month. The patient was managing with oral morphine. It was indicated the pump replacement and catheter replacement would be postponed until (b)(6) 2016. On (b)(6) 2016 the patient had a follow-up appointment for her medication regarding management for her chronic lumbar pain secondary to degenerative disc disease, post laminectomy syndrome, as well as a pre-evaluation for her intrathecal pump and catheter replacement. The patient had not been cleared by her family practice doctor. The patient was to continue with morphine for breakthrough pain and follow-up with her cardiologist. Once cleared, the plan was to proceed with the pump replacement and catheter revision. On (b)(6) 2016 the patient was seen for a follow-up appointment for her medication regarding management for her chronic lumbar pain and radiculopathy secondary to post-laminectomy syndrome and degenerative disc disease. The patient was debating whether or not to have the pump replaced, versus explanted. The patient¿s oral medications were adjusted, with instructions to follow-up in one month for re-evaluation. On (b)(6) 2016 the patient was seen for a follow-up on medication management for chronic lumbar pain with lumbar radiculopathy secondary to post-laminectomy syndrome and degenerative disc disease. The patient did not wish to pursue any replacement of her pump. No further complications were reported or anticipated.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received from a healthcare professional (hcp) on (b)(6) 2018 indicated the cause of the pump extremely tilted and rotated/pump movement was unknown. It was noted that the pump movement began sometime in 2015. No actions/interventions were noted in the patient's chart besides manipulation. The pump and catheter status were noted to be off/safe mode and has not been in use since 2015. No further complications were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSYNCHROMED II
Type of DevicePUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MDT PUERTO RICO OPERATIONS CO
rd 31 km 24 hm 4
juncos PR 00777
Manufacturer (Section G)
MDT PUERTO RICO OPERATIONS CO
rd 31 km 24 hm 4
juncos PR 00777
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key7683022
MDR Text Key113867000
Report Number3004209178-2018-15641
Device Sequence Number1
Product Code LKK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation
Type of Report Initial,Followup,Followup
Report Date 10/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/12/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator
Device Expiration Date11/14/2012
Device Model Number8637-40
Device Catalogue Number8637-40
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received08/08/2018
Was Device Evaluated by Manufacturer? No Answer Provided
Date Device Manufactured05/27/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 07/12/2018 Patient Sequence Number: 1
-
-